These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21372358)

  • 21. Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis.
    Sinagra E; Perricone G; D'Amico M; Tinè F; D'Amico G
    Aliment Pharmacol Ther; 2014 Mar; 39(6):557-68. PubMed ID: 24461301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta blockers and cirrhosis, 2016.
    Mandorfer M; Reiberger T
    Dig Liver Dis; 2017 Jan; 49(1):3-10. PubMed ID: 27717792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Band ligation versus sclerotherapy for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Gana JC; Cifuentes LI; Gattini D; Torres-Robles R
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD011803. PubMed ID: 33164205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Band ligation versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Gana JC; Cifuentes LI; Gattini D; Villarroel Del Pino LA; Peña A; Torres-Robles R
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD010546. PubMed ID: 31550050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal bleeding: Carvedilol-the best beta-blocker for primary prophylaxis?
    Tsochatzis EA; Triantos CK; Burroughs AK
    Nat Rev Gastroenterol Hepatol; 2009 Dec; 6(12):692-4. PubMed ID: 19946301
    [No Abstract]   [Full Text] [Related]  

  • 27. Primary prophylaxis of variceal bleeding.
    Simonetto DA; Shah VH; Kamath PS
    Clin Liver Dis; 2014 May; 18(2):335-45. PubMed ID: 24679498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic Management of Portal Hypertension.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2019 Nov; 23(4):713-736. PubMed ID: 31563219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011561. PubMed ID: 33522602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.
    Zoller WG; Gross M
    Eur J Med Res; 1996 Jun; 1(9):407-16. PubMed ID: 9353240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sclerotherapy versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD011573. PubMed ID: 32133620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of carvedilol and propranolol on circulatory regulation and oxygenation in cirrhosis: a randomised study.
    Hobolth L; Bendtsen F; Hansen EF; Møller S
    Dig Liver Dis; 2014 Mar; 46(3):251-6. PubMed ID: 24290869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic diagnosis and management of esophagogastric variceal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
    Gralnek IM; Camus Duboc M; Garcia-Pagan JC; Fuccio L; Karstensen JG; Hucl T; Jovanovic I; Awadie H; Hernandez-Gea V; Tantau M; Ebigbo A; Ibrahim M; Vlachogiannakos J; Burgmans MC; Rosasco R; Triantafyllou K
    Endoscopy; 2022 Nov; 54(11):1094-1120. PubMed ID: 36174643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol.
    Steib CJ; Gerbes AL
    Hepatol Int; 2017 Mar; 11(2):141-142. PubMed ID: 28233256
    [No Abstract]   [Full Text] [Related]  

  • 35. Beta-blockers versus placebo or no intervention for primary prophylaxis of oesophageal variceal bleeding in children with chronic liver disease or portal vein thrombosis.
    Cifuentes LI; Gattini D; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011973. PubMed ID: 33498095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portal hypertension and gastrointestinal bleeding: diagnosis, prevention and management.
    Biecker E
    World J Gastroenterol; 2013 Aug; 19(31):5035-50. PubMed ID: 23964137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension.
    Tripathi D; Therapondos G; Lui HF; Stanley AJ; Hayes PC
    Aliment Pharmacol Ther; 2002 Mar; 16(3):373-80. PubMed ID: 11876689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight?
    Burza MA; Marschall HU; Napoleone L; Molinaro A
    Pharmacol Res; 2017 May; 119():20-26. PubMed ID: 28099882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sclerotherapy versus beta-blockers for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis.
    Gattini D; Cifuentes LI; Torres-Robles R; Gana JC
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011659. PubMed ID: 31922266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.